Edwards Lifesciences (EW) PT Raised to $139 at UBS Amid Strong Q2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Edwards Lifesciences (EW) PT Raised to $139 at UBS Amid Strong Q2

Edwards Lifesciences Reports Second Quarter Results

July 26, 2016 4:15 PM EDT

IRVINE, Calif., July 26, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2016.

Second Quarter Highlights:

Sales grew 23.1% to $759.3 million; underlying1 sales were up 21% Global Transcatheter Heart Valve Therapy (THVT) sales grew 48.7%; underlying grew 45% U.S. THVT sales were up 71.5%; underlying grew 66% GAAP EPS was $0.58, an increase of 13.7%; adjusted2 EPS grew 33% to $0.76 2016... More